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With the cloning the lin-4 gene in 1993, the possibility of an 
approximately 21-nucleotide RNA functioning as a regulatory 
molecule intrigued a relatively small number of scientists. This 
idea appeared to be a peculiarity of C. elegans as it was not until 
seven years later that the second, more conserved small RNA, 
let-7 was cloned. A spate of papers in 2000 and 2001 revealed 
that the underlying properties of the lin-4 and let-7 genes were a 
common facet of animal genomes and the absolute number and 
potential of this new class of gene products requires us to integrate 
them with other aspects of gene expression and evolution.1-3 A 
wealth of information has accumulated in the intervening years 
that outline, in general, how these small RNAs are expressed 
and processed into a functional form. Contemporaneous to these 
studies, experiments also identified a cadre of evolutionarily 
conserved proteins, the Argonautes (Agos) that directly associate 
with and are required for microRNA function. Computational and 
experimental methods have led the identification of many func-
tional mRNA targets. In the last few years, a significant body of 
work has focused on resolving two key issues: How do microRNAs 
function in particular genetic contexts (i.e., as “molecular switches” 
or “fine-tuners” of gene expression) and secondly, what facet/s of 
mRNA metabolism do microRNAs modulate in their role(s) as a 
regulatory molecule? The primary objective here is not to compre-
hensively compare the competing models of microRNA function 
(reviewed in refs. 4–6) but to frame a potential solution to these 
two fundamental questions by suggesting that the core microRNA-
Ribonucleic-Protein Complex (microRNP), composed of the 
microRNA and an Ago protein, functions as a highly modifiable 
scaffold that associates with specific mRNAs via the bound 
microRNA and facilitates the localized activity of a variety of acces-
sory proteins. The resulting composite mechanism could account 
for the apparent complexities of measuring microRNA activity and 
furthermore, accommodate the broad levels of regulation observed 
in vivo.
[RNA Biology 5:3, 123-127; July/August/September 2008]; ©2008 Landes Bioscience
Mechanisms of microRNA Activity
A variety of mechanisms have been proposed to account for the 
dramatic effects microRNAs have on regulated transcripts. With a 
broad stroke, the mechanisms can be grouped into separate categories 
that modulate three possibly coupled facets of cytoplasmic mRNA 
metabolism: translation, mRNA localization and destabilization. 
Experimental assays designed to identify a single mechanism that 
explains the activity of microRNAs are complicated by the fact none 
of the highly tractable in vitro or in vivo systems leads to more than 
the two- to five-fold microRNA-dependent repression of heterolo-
gous reporters. This is in striking contrast to the almost complete 
repression of target gene expression afforded by some microRNAs 
in their endogenous context (lsy-6, lin-4 etc.,).7-13 Furthermore, 
particular microRNAs often differ in their overall effect on gene 
regulation; some microRNAs function as molecular switches within 
a genetic circuit while other microRNAs simply titrate or “fine tune” 
gene expression levels within a genetic pathway.14,15 Nevertheless, 
all endogenous and reporter-based assays that measure microRNA-
mediated repression clearly indicate that Ago proteins, via their 
ability to mediate protein-protein and protein-RNA interactions, 
are at the core of this form of regulation.
Three reports strongly indicate that part of microRNA-mediated 
repression may be accomplished by inhibiting the very earliest phases 
of mRNA translation. Kiriakidou et al. found that hAgo2 contains 
a stretch of amino acids with limited homology to a domain found 
in the translation initiation factor eIF4E required for mRNA cap-
structure binding (Fig. 1A). Although the two proteins share little 
overall similarity, both proteins can bind the m7G cap structure 
found on mRNAs. Mutations in the conserved aromatic residues 
of this inner Argonaute domain (termed the MC domain) ablate 
cap-structure binding by Ago2.16 Because translational initiation 
proceeds through a complex interplay between the 5'-cap and 3' 
termini of the mRNA and this end-to-end linking is facilitated by 
eIF4E (the cap binding protein), eIF4G, and the poly A tail binding 
protein (PABP1), the authors propose a model in which hAgo2 
competes with eIF4E for cap binding and reduces translation by 
limiting access of initiation factors to the 5' end of the transcript 
(Fig. 1A). Their experiments also demonstrate that mutations in 
the MC domain prevent Ago2 from binding the m7G cap struc-
ture but do not inhibit all Ago2-related activities (mutant Ago2 
retains its ability to bind microRNAs and RNAi “slicing” activites). 
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MC domain mutations dramatically reduce 
translational repression of experimentally 
targeted reporters.16 Consistent with the 
competition model, Thermann and Hentze 
and Mathonnet et al. both developed cell 
free systems that recapitulate microRNA 
regulation and find that repression occurs 
at the initiation step of polyribosome 
formation. Thermann and Hentze find that 
transcripts repressed by mirR-2 quickly 
associate with an uncharacterized set of 
RNA-binding proteins that are molecu-
larly distinct from proteins associated with 
translated mRNAs.17 In the reconstituted 
reactions described by Mathonnett et al. 
microRNA activity leads to the rapid 
inhibition of mRNA translation and this 
repressive activity is sensitive to the levels 
of eIF4F present in extracts (an additional 
component of the cap-binding complex). 
As would be predicted from a competition-
based mechanism, addition of excess eIF4F 
can overcome microRNA-mediated repres-
sion.18 All three groups demonstrate that 
mRNAs utilize Internal Ribosomal Entry 
Sites (IRES, that bypass the requirement 
for most translational initiation factors) 
are resistant to microRNA repression. The 
in vitro system developed by Mathonnet 
also allowed the authors to demonstrate 
that transcripts containing an alternative 
cap structure (ApppG) were also refractory 
to microRNA-mediated repression, further 
indicating mRNA cap structure and trans-
lation initiation factors (the cap-binding 
complex) play a role in microRNA medi-
ated repression.18
The elegant experiments described 
above suggest that at least some portion of 
microRNA-mediated repression occurs by 
the inhibition of translational initiation. 
Other lines of evidence suggest that microRNA-mediated regulation 
is more complicated. Initial biochemical analysis in C. elegans suggest 
that two lin-4 mRNA targets, lin-14 and lin-28 are associated with 
polysomes both before (in early larval stage extracts) and during 
lin-4 microRNA-mediated repression (in extracts of second larval 
stage animals).19,20 This lead to the initial speculation that much of 
the lin-4-mediated repression occurs after translational initiation on 
transcripts that contain multiple, engaged ribosomes. The general 
nature of this proposed model is not limited to C. elegans. Multiple, 
independent studies using separate cultured cell lines also observed 
a polysomal association of transfected reporters under conditions in 
which endogenous or experimentally supplemented microRNAs were 
actively repressing these transcripts.21-23 In each of the experimental 
systems outlined above the authors went to great lengths to show 
that the mobility of the repressed target transcripts in sucrose gradi-
ents was altered by a variety of conditions and drug treatments that 
disrupt engaged, 80S ribosomal subunits. In addition to these obser-
vations, a significant proportion many microRNAs are associated 
with the heavy fractions of polysomal gradients and their mobility 
in these gradients is limited by conditions that dissociate engaged 
ribosomes.22,23 The mechanistic interpretations forwarded from 
these experiments included co-translational polypeptide destruc-
tion, peptidyl-transferase inhibition and ribosomal disassociation. 
Unfortunately, there is no direct experimental evidence to bolster any 
of these models as none of the components mediating any of these 
biochemical activities have been identified.
mRNA degradation has also emerged as a candidate mecha-
nism for post-transcriptional repression mediated by microRNAs. 
Argonaute bound microRNAs effect mRNA turnover by at least 
three separate mechanisms: endonucleolytic cleavage and de-capping 
and deadenylation. In rare cases such as the evolutionally conserved 
regulation of mammalian HOXB8, miR-196 perfectly base pairs with 
Figure 1. The microRNA/Argonaute complex functions as a molecular scaffold that modulates mRNA 
expression. (A) The miRNP complex recognizes target transcripts though interactions between the 
microRNA and partially complementary sequences in their 3'UTRs. As a consequence, the miRNP can 
modulate several aspects of mRNA metabolism. (B) The core components of the miRNP, the microRNA 
and Argonaute, can regulate mRNA targets through protein motifs that can directly interact with mRNA 
structures and translation initiation factors. (C) The core miRNP can interact with additional cofactors 
that mediate specific facets of mRNA regulation. The activity of each co-factor is independent of the 
other and are additive with regard to regard to the final levels of regulation on a target transcript. 
(D) Under specific circumstances or unique environments (i.e., serum starvation or within the germ line), 
the associations between the core miRNP and cofactors can be regulated by post-translational modifica-
tion and or co-factor substitution. In this context, the resulting composite activity of a given microRNA can 
differ dramatically from its apparent activity in other conditions.
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elements in the HOXB8 3'UTR causing the associated Argonaute 
protein to engage its “slicer” activity.24,25 The HOXB8 transcript 
is cleaved between positions 10 and 11 relative to the 5' end of the 
microRNA as would happen with a siRNA mediated mechanism. 
“Sliced” HOXB8 transcripts are then degraded by the conventional 
RNA turnover components.25
In addition to the unconventional role of miR-196 in HOXB8 
regulation, there are several clear reports that the activity of 
microRNAs lead to a dramatic enhancement of target mRNA 
turnover and the mechanism is fundamentally distinct from the endo-
nucleolyticly-initiated cleavage mediated by the RNase H domains of 
the Ago proteins.26-28 This observation has been used to identify 
and even validate several microRNA targets in vivo.29,30 The clearest 
example of this type of microRNA-mediated regulation takes place 
during the transition from early, maternally supplied gene expression 
to that of zygotic transcribed mRNAs in the embryos of Zebrafish. 
Concurrent with the expression of early zygotic mRNA expres-
sion, miR-430 transcription is initiated.31 Surprisingly, a significant 
percentage of maternally contributed transcripts (deposited during 
oogenesis) contain partially complementary miR-430 binding sites. 
miR-430 activity leads to the dramatic deadenylation of several 
maternally loaded target mRNAs and the presence of this microRNA 
correlates with the active degradation of hundreds of maternal tran-
scripts.31 Consistent with the specificity of this microRNA-mediated 
degradation, experimental ablation of miR-430 (via antisense oligo-
nucleotides) leads to the inappropriate and continued expression of 
many maternal transcripts and the stabilization of specific, miR-430 
regulated mRNAs.31
The generality of microRNA-mediated mRNA turnover can be 
verified in a variety of in vivo systems. In a tractable in vitro system 
this mode of repression can be shown to occur independently of 
translation.32,33 Importantly, genetic ablation or knock-down (using 
RNA-interference) of a variety of known mRNA decay-pathway 
components [including decapping enzyme DCP1 and de-capping 
activators (e.g., RCK/p54 DCP1)] demonstrate that microRNA-
mediated mRNA degradation occurs though this well characterized 
pathway.26-28,32 However, the overall repressive activity contributed 
by this mechanism is hard to quantify since the microRNA-depen-
dent decrease in target mRNA abundance is strongly dependent on 
the inherent stability and half-life of the targeted transcript as well 
as its relationship to a given microRNA. In addition, the location, 
number and context of all microRNA binding sites on a given UTR 
may dictate much of the overall turnover rate.30,34 In a process that 
clearly requires cellular components related to mRNA turnover, 
microRNAs and their targets can also be compartmentally local-
ized to several types of cytoplasmic foci including cytoplasmic 
processing bodies (P-bodies) or stress granules.21,35-37 Although our 
current understanding of these subcellular compartments is only 
beginning to mature, two things are clear: (1) P-bodies and stress 
granules are not specific to microRNA-mediated forms of regula-
tion, as most transcripts require the many of these components for 
normal mRNA turnover and (2) although several Argonaute proteins 
directly interact with some of the core components that define these 
structures, microRNAs can still inhibit the translation of their target 
transcripts in conditions that disrupt these complexes.27,37,38
…And microRNAs Can Function Positively
Two papers from the Steitz laboratory have fundamentally altered 
our understanding of the full potential of microRNA function and 
require a more generalized view of how these molecules operate in 
complex with Argonaute proteins. In contrast to the generally held 
assumption that microRNAs only mediate a repressive function on 
targeted mRNAs, Vasudevan and Steitz found that, under specific 
environmental conditions, microRNAs positively affect mRNA 
translation. Vasudevan et al. stumbled across this microRNA-
mediated activity obliquely by characterizing a now classic model 
for mRNA destabilization mediated by AU-rich elements found 
in particular, post-transcriptionally regulated 3'UTRs (reviewed in 
ref. 39). Initially they observed that AU-rich elements of particular 
mRNAs [elements that under proliferative growth conditions lead to 
the elevated mRNA turnover (e.g., TNFα)] can stimulate translation 
under conditions of serum starvation.40 Through affinity purifica-
tion, Vasudevan and Steitz found that both Ago2 and a relative of a 
previously identified Ago2-interacting protein, the fragile-X-mental-
retardation-related protein 1 (FXR1), both physically associate with 
translationally activated mRNAs and are required for the elevated 
translation in serum-starved environments.40,41 Computational and 
candidate testing revealed that a particular microRNA, miR-396-3, 
is highly expressed in serum-starved conditions, is complementary 
to the AU-rich element found in TNFα and is required for transla-
tional activation under these conditions. Further characterization of 
other microRNAs, including let-7 and even a synthetic microRNA 
miRcxcr-4, revealed that all microRNAs tested in these conditions 
could stimulate translation of mRNAs that contained cognate 
microRNA binding sites.41 The Ago2 dependent repression or stimu-
lation of translation could also be shown to function completely as a 
trans-acting protein complex by tethering a λN-tagged Ago2 protein 
to a mRNA transcript bearing the 5B-box RNA structural element to 
which the λN-protein binds with high affinity.41
Argonaute Proteins Provide a Molecular Platform  
for microRNA Activity
How can microRNAs function to regulate so many facets of 
mRNA metabolism and, in alternative environmental conditions, 
function in both a positive and negative manner? Furthermore, how 
can some microRNAs appear to function as “switches” and in other 
contexts merely “fine-tune” gene expression? The results outlined by 
Vasedevan et al. imply that the core components of the microRNA/
Argonaute complex do not change and both the microRNA and 
Argonaute are required for both repressive and translational acti-
vating functions.41 This suggests that Ago2 functions as a “scaffold” 
or “platform” that is targeted to particular mRNAs via specific base 
pairing by the bound microRNA. This scaffold can then be modu-
lated by environmental, physiological or developmental inputs. 
In the case of translational activation, both the specific microRNA 
(or at least the ability to bind microRNAs) and a specific protein 
co-factor, FXR1, are required. Importantly, FXR1 does not appear to 
function in microRNA mediated repression and can not contribute to 
translational stimulation in the absence of a functional Argonaute.41 
One of the most intriguing ideas illuminated in these findings is 
that the modulation of Ago2 activity by FXR1 and serum starvation 
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is not a peculiarity of transcripts that contain AU-rich destabilizing 
elements but a variation of the standard mechanism of microRNA 
function.
One can imagine a solution for all competing mechanisms 
(Fig. 1A) proposed to answer the ultimate question of “how do 
microRNAs regulate target transcripts.” Perhaps these are not 
competing models but are descriptions of many “true” mechanisms 
that occur in vivo. In each of the experimental systems used to 
“isolate” a particular mechanism, the experimenters have gone to 
great lengths to provide the proper controls and quantification 
to forward their particular hypothesis. Even the most convincing 
experimental systems typically only display between a two- to five-
fold reduction in reporter expression which is typically articulated as 
the relative change in reporter expression compared to an additional, 
experimentally supplied, non-regulated reporter. Additionally, the 
calculation of the fold repression is complicated by the fact that 
mRNA transcripts typically give rise to more than one polypeptide 
in their lifetime and experimenters only measure the cumulative 
output of reporter expression that is distributed in a population 
of cells. In these experiments, culture conditions vary greatly and 
tissues or cells used in these assays are not always homogeneous in 
nature or physiological state (i.e., different cell cycle stage, serums 
conditions etc.). An alternative interpretation of a two- to five-fold 
level of repression would be that a given microRNA completely (i.e., 
irreversibly) represses just fifty percent (for two-fold reduction) to 
eighty percent (for five-fold) of the available targets in the population 
cells and the remaining portion of the reporter is not effected at all. 
Although there is a plethora of accumulating evidence that several 
endogenous microRNAs regulate their target transcripts within these 
physiological ranges (one- to two-fold), most of the microRNAs 
identified by forward genetic screens typically regulate the expression 
of there target transcripts in dramatic, almost “on” to “off,” switch-
like manner.7-13 This leaves open the question of wheter microRNA 
regulation is much more effective for these “switch-like” targets, in 
vivo, or whether many mechanisms contribute to the total regulation 
of these targets.
One exception to the proceeding set of statements is the case of 
microRNA regulation of maternally loaded transcripts where much 
of the regulation can be accounted for by the single mechanism of 
active de-adenylation and subsequent degradation.31 In this example, 
the regulation via miR-430 takes place in a very restricted and 
specialized environment. In this environment, one could imagine 
that the microRNP found in maturing embryos (which would be 
primarily loaded with miR-430 as it is one of the first zygotically 
transcribed microRNAs) could contain additional, germ-line specific 
protein components. These germ-line specific components would 
augment the normally modest levels of translational repression 
mediated by the streamlined, basal Argonaute/microRNA complex 
(Fig. 1B and C). A similar mechanism for augmenting basal 
Argonaute/microRNA complex activity could exist in serum starved 
cells where FXR1 association with the miRNP completely changes 
the apparent activity of this complex to one of translational stimu-
lation. This could be accomplished by exchanging co-factors that 
normally repress mRNA expression for a wholly different set of 
components that lead to translational stimulation in serum starved 
conditions (Fig. 1C and D).
With this relatively simple hypothesis of a modular miRNP 
complex, one can begin to accommodate all of the experimental 
data that separately suggests a variety of disparate mechanisms for 
microRNA activity. In this hypothesis, the Argonaute and microRNA 
form the minimal inhibitory complex that leads to a basal level of 
microRNA-mediated repression (Fig. 1B). Repression would be 
mediated by the sequence specific recognition of the microRNA and 
the physical nature of the Argonaute protein and its ability to interact 
with fundamental and common structures (the m7G cap structure) 
found in target transcripts and particular proteins (initiation factors 
and ribosomal recycling components) required for translation. The 
absolute level of inhibition mediated by this baseline activity may 
only represent the modest levels of regulation (one to two fold) seen 
in a variety of experimental assays.
Depending on the cellular context (i.e., cell type, developmental 
or physiological status etc.,) the core or minimal Argonaute/
microRNA complex may associate with a variety of auxiliary proteins 
(Fig. 1C and D). Each of these auxiliary proteins could indepen-
dently modulate the expression of a microRNA-targeted transcript. 
For instance, a given Argonaute/microRNA complex may contain 
co-factors that mediate critical interactions between P-body compo-
nents, translational elongation machinery or even components of 
protein degradation machinery. In this scenario, the absolute level 
of regulation observed for a particular microRNA/target pair would 
be the composite of a variety of activities particular to the miRNP 
complex. Because the activity of a given microRNA would be a 
composite of these various physical interactions, each module could 
be individually regulated by post-translational modification of the 
co-factor itself or its interaction surface found on the Argonaute 
protein. This type of regulation would allow for exquisite control of 
the activity of a given microRNA or microRNAs. Additionally, due 
to the three dimensional structure of the basal Argonaute/microRNA 
complex, there would be sufficient structural information in the 
microRNA/target interaction to envision specificity factors. These 
specificity factors would recognize specific bulges or free sequence 
elements common to subsets of microRNA/target interactions. In 
this case, different targets of a given microRNA may display different 
levels of regulation depending on their ability to interact with one of 
these hypothetical specificity factors. Several reports have identified 
Argonaute interacting proteins that themselves have very specific 
phenotypes when mutated suggesting that they are not general 
components of the basal Argonaute/microRNA complex and there-
fore do not effect the function of all microRNAs.42-44
In summary, the idea that small RNAs could specifically regulate 
mRNA expression has already had a dramatic impact on modern 
biological research. It is hard to imagine how such relatively small 
snippets of RNA can lead to dramatic changes in target stability, 
translation and localization. One thin is clear: at the center of these 
interactions lie the Argonaute proteins. With the detailed char-
acterization of additional microRNA/target interactions and the 
identification of the protein complexes that mediate their regulatory 
outcomes, one can only expect the list of Argonaute/microRNA 
cofactors to grow. For this reason alone, the core Argonaute/
microRNA complex will remain the reference point of microRNA 
research.
© 
20
09
 LA
ND
ES
 BI
OS
CIE
NC
E. 
DO
 NO
T D
IST
RIB
UT
E.
The microRNA-argonaute complex: A platform for mRNA modulation
www.landesbioscience.com RNA Biology 127
References
 1. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T. Identification of novel genes 
coding for small expressed RNAs. Science 2001; 294:853-8.
 2. Lau NC, Lim LP, Weinstein EG and Bartel DP. An abundant class of tiny RNAs with prob-
able regulatory roles in Caenorhabditis elegans. Science 2001; 294:858-62.
 3. Lee RC and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 
2001; 294:862-4.
 4. Eulalio A, Huntzinger E and Izaurralde E. Getting to the root of miRNA-mediated gene 
silencing. Cell 2008; 132:9-14.
 5. Wu L and Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs 
and siRNAs. Mol Cell 2008; 29:1-7.
 6. Filipowicz W, Bhattacharyya SN and Sonenberg N. Mechanisms of post-transcriptional 
regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9:102-14.
 7. Johnston RJ and Hobert O. A microRNA controlling left/right neuronal asymmetry in 
Caenorhabditis elegans. Nature 2003; 426:845-9.
 8. Brennecke J, Hipfner DR, Stark A, Russell RB and Cohen SM. bantam encodes a develop-
mentally regulated microRNA that controls cell proliferation and regulates the proapoptotic 
gene hid in Drosophila. Cell 2003; 113:25-36.
 9. Slack FJ, et al. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between 
the let-7 regulatory RNA and the LIN-29 transcription factor. Mol Cell 2000; 5:659-69.
 10. Moss EG, Lee RC and Ambros V. The cold shock domain protein LIN-28 controls devel-
opmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 1997; 88:637-46.
 11. Lee RC, Feinbaum RL and Ambros V. The C. elegans heterochronic gene lin-4 encodes small 
RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-54.
 12. Wightman B, Ha I and Ruvkun G. Posttranscriptional regulation of the heterochronic gene 
lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75:855-62.
 13. Abbott AL, et al. The let-7 MicroRNA family members mir-48, mir-84 and mir-241 func-
tion together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 2005; 
9:403-14.
 14. Karres JS, Hilgers V, Carrera I, Treisman J and Cohen SM. The conserved microRNA miR-8 
tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007; 131:136-45.
 15. Simon DJ, et al. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at 
neuromuscular junctions. Cell 2008; 133:903-15.
 16. Kiriakidou M, et al. An mRNA m7G cap binding-like motif within human Ago2 represses 
translation. Cell 2007; 129:1141-51.
 17. Thermann R and Hentze MW. Drosophila miR2 induces pseudo-polysomes and inhibits 
translation initiation. Nature 2007; 447:875-8.
 18. Mathonnet G, et al. MicroRNA inhibition of translation initiation in vitro by targeting the 
cap-binding complex eIF4F. Science 2007; 317:1764-7.
 19. Seggerson K, Tang L and Moss EG. Two genetic circuits repress the Caenorhabditis elegans 
heterochronic gene lin-28 after translation initiation. Dev Biol 2002; 243:215-25.
 20. Olsen PH and Ambros V. The lin-4 regulatory RNA controls developmental timing in 
Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of transla-
tion. Dev Biol 1999; 216:671-80.
 21. Bhattacharyya SN, Habermacher R, Martine U, Closs EI and Filipowicz W. Stress-induced 
reversal of microRNA repression and mRNA P-body localization in human cells. Cold 
Spring Harb Symp Quant Biol 2006; 71:513-21.
 22. Nottrott S, Simard MJ and Richter JD. Human let-7a miRNA blocks protein production 
on actively translating polyribosomes. Nat Struct Mol Biol 2006; 13:1108-14.
 23. Maroney PA, Yu Y, Fisher J and Nilsen TW. Evidence that microRNAs are associated with 
translating messenger RNAs in human cells. Nat Struct Mol Biol 2006; 13:1102-7.
 24. Liu J, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 
305:1437-41.
 25. Yekta S, Shih IH and Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 
2004; 304:594-6.
 26. Bagga S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. 
Cell 2005; 122:553-63.
 27. Behm-Ansmant I, et al. mRNA degradation by miRNAs and GW182 requires both CCR4:
NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 2006; 20:1885-98.
 28. Chendrimada TP, et al. MicroRNA silencing through RISC recruitment of eIF6. Nature 
2007; 447:823-8.
 29. Lim LP, et al. Microarray analysis shows that some microRNAs downregulate large numbers 
of target mRNAs. Nature 2005; 433:769-73.
 30. Grimson A, et al. MicroRNA targeting specificity in mammals: determinants beyond seed 
pairing. Mol Cell 2007; 27:91-105.
 31. Giraldez AJ, et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal 
mRNAs. Science 2006; 312:75-9.
 32. Wakiyama M, Takimoto K, Ohara O and Yokoyama S. Let-7 microRNA-mediated mRNA 
deadenylation and translational repression in a mammalian cell-free system. Genes Dev 
2007; 21:1857-62.
 33. Eulalio A, Huntzinger E and Izaurralde E. GW182 interaction with Argonaute is essential 
for miRNA-mediated translational repression and mRNA decay. Nat Struct Mol Biol 2008; 
15:346-53.
 34. Eulalio A, et al. Target-specific requirements for enhancers of decapping in miRNA-medi-
ated gene silencing. Genes Dev 2007; 21:2558-70.
 35. Leung AK, Calabrese JM and Sharp PA. Quantitative analysis of Argonaute protein reveals 
microRNA-dependent localization to stress granules. Proc Natl Acad Sci USA 2006; 
103:18125-30.
 36. Chu CY and Rana TM. Translation repression in human cells by microRNA-induced gene 
silencing requires RCK/p54. PLoS Biol 2006; 4:210.
 37. Eulalio A, Behm-Ansmant I, Schweizer D and Izaurralde E. P-body formation is a conse-
quence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 2007; 27:3970-81.
 38. Parker R and Sheth U. P bodies and the control of mRNA translation and degradation. Mol 
Cell 2007; 25:635-46.
 39. Wilusz CJ, Wormington M and Peltz SW. The cap-to-tail guide to mRNA turnover. Nat 
Rev Mol Cell Biol 2001; 2:237-46.
 40. Vasudevan S and Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 
and Argonaute2. Cell 2007; 128:1105-18.
 41. Vasudevan S, Tong Y and Steitz JA. Switching from repression to activation: microRNAs 
can upregulate translation. Science 2007; 318:1931-4.
 42. Neumuller RA, et al. Mei-P26 regulates microRNAs and cell growth in the Drosophila 
ovarian stem cell lineage. Nature 2008.
 43. Ishizuka A, Siomi MC and Siomi H. A Drosophila fragile X protein interacts with compo-
nents of RNAi and ribosomal proteins. Genes Dev 2002; 16:2497-508.
 44. Jing Q, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. 
Cell 2005; 120:623-34.
